UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The microbial metabolite desaminotyrosine protects from influenza through type I interferon

Science (American Association for the Advancement of Science), 2017-08, Vol.357 (6350), p.498-502

2017

Volltextzugriff (PDF)

Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration

Cell host & microbe, 2018-09, Vol.24 (3), p.353-363.e5

2018

Volltextzugriff (PDF)

Induction of IL-33 expression and activity in central nervous system glia

Journal of leukocyte biology, 2008-09, Vol.84 (3), p.631-643

2008

Volltextzugriff (PDF)

SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients

Laboratory investigation, 2008-03, Vol.88 (3), p.243-255

2008

Volltextzugriff (PDF)

Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Clinical gastroenterology and hepatology, 2021-08, Vol.19 (8), p.1592-1601.e3

2021

Volltextzugriff (PDF)

Modulation of Macrophage Infiltration and Inflammatory Activity by the Phosphatase SHP-1 in Virus-Induced Demyelinating Disease

Journal of Virology, 2009-01, Vol.83 (2), p.522-539

2009

Volltextzugriff (PDF)

Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients

Clinical immunology (Orlando, Fla.), 2012-03, Vol.142 (3), p.308-319

2012

Volltextzugriff (PDF)

Immune markers and differential signaling networks in ulcerative colitis and Crohnʼs disease

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2342-2356

2012

Volltextzugriff (PDF)

Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2342-2356

2012

Volltextzugriff (PDF)

Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab

Inflammatory bowel diseases, 2019-06, Vol.25 (7), p.e87-e88

2019

Volltextzugriff (PDF)

Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium

Clinical gastroenterology and hepatology, 2021-10, Vol.19 (10), p.2207-2209.e3

2021

Volltextzugriff (PDF)

Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia

Journal of neurochemistry, 2008-06, Vol.105 (6), p.2511-2523

2008

Volltextzugriff (PDF)

Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-controlled Crohn's Disease

The American journal of gastroenterology, 2018-11, Vol.113 (11), p.1732-1733

2018

Volltextzugriff (PDF)

Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response

Biological chemistry, 2014-09, Vol.395 (9), p.1063-1073

2014

Volltextzugriff (PDF)

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach

Clinical and Experimental Gastroenterology, 2016-01, Vol.9 (Issue 1), p.125-130

2016

Volltextzugriff (PDF)

Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype

Laboratory investigation, 2009-07, Vol.89 (7), p.742-759

2009

Volltextzugriff (PDF)

Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?

Journal of clinical gastroenterology, 2015-08, Vol.49 (7), p.539-540

2015

Volltextzugriff (PDF)

Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis

Experimental and molecular pathology, 2014-06, Vol.96 (3), p.393-399

2014

Volltextzugriff (PDF)

The control of reactive oxygen species production by SHP-1 in oligodendrocytes

Glia, 2015-10, Vol.63 (10), p.1753-1771

2015

Volltextzugriff (PDF)

Erdheim-Chester Disease presenting with histiocytic colitis and cytokine storm

Journal of gastrointestinal and liver diseases : JGLD, 2017-06, Vol.26 (2), p.183-187

2017

Volltextzugriff (PDF)

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients

Journal of the neurological sciences, 2011-08, Vol.307 (1), p.41-45

2011

Volltextzugriff (PDF)

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN- beta 1a treated multiple sclerosis patients

Journal of the neurological sciences, 2011-08, Vol.307 (1-2), p.41-45

2011

Volltextzugriff (PDF)

Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1

Viral immunology, 2009-12, Vol.22 (6), p.371-387

2009

Volltextzugriff (PDF)

Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

Clinical immunology (Orlando, Fla.), 2009-10, Vol.133 (1), p.27-44

2009

Volltextzugriff (PDF)

Quality Improvement Indicators in Inflammatory Bowel Disease

Advanced research in gastroenterology & hepatology, 2017-05, Vol.5 (4)

Christophi, George P

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(47)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(18)
Female
(15)
Male
(11)
Adult
(9)
Animals
(9)
Biological And Medical Sciences
(9)
Gastroenterology & Hepatology
(9)
Mice
(9)
Inflammation
(8)
Medical Sciences
(8)
Middle Aged
(8)
Cytokines
(7)
Gene Expression
(7)
Cells, Cultured
(6)
Multiple Sclerosis
(6)
Protein Tyrosine Phosphatase, Non-Receptor Type 6 - Genetics
(6)
Fundamental And Applied Biological Sciences. Psychology
(5)
Inflammatory Bowel Disease
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The microbial metabolite desaminotyrosine protects from influenza through type I interferon

Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration

Induction of IL-33 expression and activity in central nervous system glia

SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients

Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

Modulation of Macrophage Infiltration and Inflammatory Activity by the Phosphatase SHP-1 in Virus-Induced Demyelinating Disease

Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients

Immune markers and differential signaling networks in ulcerative colitis and Crohnʼs disease

Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease

Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab

Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium

Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia

Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-controlled Crohn's Disease

Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach

Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype

Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?

Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis

The control of reactive oxygen species production by SHP-1 in oligodendrocytes

Erdheim-Chester Disease presenting with histiocytic colitis and cytokine storm

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN- beta 1a treated multiple sclerosis patients

Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1

Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

Quality Improvement Indicators in Inflammatory Bowel Disease

Suchergebnisse filtern